Prognostic implications of combining EGFR‐TKIs and radiotherapy in Stage IV lung adenocarcinoma with 19‐Del or 21‐L858R mutations: A real‐world study

Documenti analoghi

• Bilateral diffuse metastases in advanced lung adenocarcinoma harboring EGFR mutations was associated with a favorable prognosis to EGFR‐TKIs
  di: Zhenbang Gu, et al.
  Pubblicazione: (2024)
• Thoracic radiotherapy synergizes with first‐line EGFR ‐ TKIs in advanced EGFR ‐mutant NSCLC : A dual‐center real‐world study
  di: Zhuoying Tian, et al.
  Pubblicazione: (2025)
• Clinical relevance of somatic mutations in Chinese lung adenocarcinoma and their prognostic implications for survival
  di: Tongxin Li, et al.
  Pubblicazione: (2024)
• Clinical Outcomes of Later‐Generation EGFR ‐ TKIs for Uncommon EGFR Mutations in NSCLC : A Multicenter Real‐World Study
  di: Lisa Shigematsu, et al.
  Pubblicazione: (2025)
• The association of genomic alterations with PD‐L1 expression in Chinese patients with EGFR/ALK wild‐type lung adenocarcinoma and potential predictive value of Hippo pathway mutations to immunotherapy
  di: Fangfang Liu, et al.
  Pubblicazione: (2024)